Transitional cell cancer of the renal pelvis and ureter is a rare cancer that develops in the cells lining the upper urinary tract, where urine collects before traveling to the bladder. This type of cancer typically affects older adults and can disrupt normal urine flow, causing pain and bleeding. Understanding how this disease progresses, its potential complications, and its impact on daily life is essential for patients and their families navigating the journey ahead.

Prognosis: Understanding Your Outlook

When you or someone you love receives a diagnosis of transitional cell cancer of the renal pelvis or ureter, one of the first questions that comes to mind is about the future. The prognosis for this cancer depends heavily on how early the disease is caught and how deeply it has invaded the tissues of the urinary tract.^[1]

If the cancer is found when it is still superficial—meaning it remains only on the surface lining of the renal pelvis or ureter without invading deeper layers—the outlook is quite encouraging. More than 90% of patients with superficial disease that is confined to these areas can be cured with appropriate treatment.^[2] These cancers are generally well-differentiated, which means the cancer cells still resemble normal, healthy cells to some degree, and they tend to behave less aggressively.

However, the prognosis becomes more guarded when the cancer has grown deeper into the wall of the renal pelvis or ureter. Patients whose tumors have invaded deeply but remain confined to these organs have approximately a 10% to 15% chance of cure.^[2] When tumors penetrate through the wall of the urinary tract or spread to distant parts of the body—a process called metastasis—the available treatments become less effective at eliminating the disease entirely.

The depth of invasion into the tissue wall is the single most important factor doctors consider when estimating prognosis. Superficial tumors that have not breached the inner lining tend to be low-grade, while deeply invasive tumors are typically high-grade and poorly differentiated, meaning their cells look very abnormal under a microscope.^[2] High-grade cancers grow more aggressively and are more likely to spread.

Another important aspect to understand is that this cancer has a tendency to appear in other parts of the urinary tract over time. Between 30% and 50% of patients who have had upper tract transitional cell cancer will later develop bladder cancer.^[2] When the cancer involves both the renal pelvis and the ureter, the likelihood of later bladder cancer increases to 75%. Additionally, 2% to 4% of patients may develop cancer in the opposite kidney or ureter at some point.^[2] This pattern reflects what doctors call “field cancerization,” where the entire lining of the urinary tract has been exposed to the same cancer-causing factors.

Natural Progression: How the Disease Develops Without Treatment

If left untreated, transitional cell cancer of the renal pelvis and ureter follows a predictable but concerning pattern of growth and spread. Understanding this natural progression helps explain why early detection and treatment are so important.

The cancer begins in the transitional cells—also called urothelial cells—that line the inside of the renal pelvis and ureters. These specialized cells have the remarkable ability to stretch when the urinary tract fills with urine and then return to their original shape when empty.^[1] When a healthy transitional cell undergoes changes that cause it to become cancerous, it begins to multiply in an uncontrolled way, forming abnormal growths.

Initially, these cancerous cells may form a small tumor on the surface of the lining. At this early stage, the tumor is considered superficial. However, without intervention, the cancer cells continue to divide and the tumor grows larger. Over time, the cancer invades deeper into the layers of the renal pelvis or ureter wall. These walls have multiple layers, including a thin layer of connective tissue called the lamina propria and an outer muscle layer called the muscularis propria.^[4]

As the tumor penetrates through these layers, it can eventually break through the outer wall entirely, spreading into the fat and connective tissue that surrounds the kidneys and ureters. At this point, the cancer is no longer contained and has a much greater chance of spreading to other organs.

The cancer can also spread through the lymphatic system, which is a network of vessels that carries fluid and immune cells throughout the body. Cancer cells may break away from the original tumor and travel through lymph vessels to nearby lymph nodes, particularly those in the retroperitoneum—the space behind the abdominal cavity. From there, cancer cells can spread even further to distant organs such as the lungs, liver, or bones.

Throughout this progression, the tumor growing in the renal pelvis or ureter creates physical problems even before it spreads. The growing mass can block the flow of urine from the kidney to the bladder, causing urine to back up. This creates pressure and swelling in the kidney, a condition called hydronephrosis, which can damage kidney function. The tumor can also bleed into the urine, leading to visible blood in the urine—the most common symptom patients notice.^[1]

Most upper tract tumors are of the transitional cell type, accounting for about 90% of cancers in these areas. However, less than 15% may be squamous cell carcinoma, which is often associated with chronic kidney stones and infection.^[2] Regardless of the exact cell type, the pattern of growth and spread follows similar principles.

Possible Complications: What Can Go Wrong

Transitional cell cancer of the renal pelvis and ureter can lead to several complications, some directly related to the tumor itself and others arising from the cancer’s spread or the treatments used to control it.

One of the most immediate complications is obstruction of the ureter. As the tumor grows, it can partially or completely block the tube that carries urine from the kidney to the bladder. This blockage prevents urine from draining properly, causing it to accumulate in the kidney. The resulting swelling and pressure can cause significant pain in the side or back, between the ribs and hips—an area doctors call the flank.^[1] If the obstruction persists, it can lead to permanent kidney damage and loss of function in that kidney.

Bleeding is another common complication. The tumor can erode into blood vessels within the urinary tract, causing blood to leak into the urine. While small amounts of blood may only be detectable under a microscope, heavier bleeding can turn the urine visibly red or brown. In severe cases, the bleeding may be heavy enough to cause anemia—a condition where the body doesn’t have enough healthy red blood cells to carry oxygen to tissues. This can result in fatigue, weakness, and shortness of breath.

Infection represents a significant risk when urine flow is blocked. Stagnant urine provides an ideal environment for bacteria to grow, potentially leading to urinary tract infections or more serious kidney infections called pyelonephritis. These infections can cause fever, chills, and worsening pain, and may require hospitalization for intravenous antibiotics.

When the cancer spreads beyond its original location, the complications become more severe and varied depending on where the metastases occur. If cancer cells reach the lymph nodes, they can continue to grow there, potentially forming new tumors that compress nearby structures. Spread to the lungs can cause coughing, chest pain, or difficulty breathing. Bone metastases may result in bone pain, fractures, or elevated calcium levels in the blood. Liver involvement can affect liver function, leading to jaundice (yellowing of the skin and eyes), abdominal swelling, or confusion.

The incidence of subsequent bladder cancer is particularly noteworthy. Between 30% and 50% of patients who have upper tract transitional cell cancer will develop bladder tumors later, usually within five years.^[2] When the original cancer involves both the renal pelvis and ureter, the risk of developing bladder cancer jumps to 75%. This pattern underscores the importance of continued bladder surveillance even after successful treatment of the upper tract cancer.

There is also a 2% to 4% risk of developing cancer in the opposite kidney or ureter.^[2] Having cancer develop on both sides presents unique challenges, as removing both kidneys would require dialysis or kidney transplant to sustain life.

Impact on Daily Life: Living With the Disease

Transitional cell cancer of the renal pelvis and ureter affects nearly every aspect of a person’s daily existence, from physical capabilities to emotional well-being, social relationships, and work life.

Physically, the symptoms of the disease itself can be disruptive and uncomfortable. Blood in the urine can be alarming and unpredictable, making some patients anxious about being far from a bathroom or embarrassed about visible bleeding. Back pain or cramps in the side can range from a dull ache to sharp, severe pain that makes it difficult to find a comfortable position for sleeping or sitting.^[1] This pain may interfere with the ability to perform routine tasks like lifting groceries, playing with grandchildren, or maintaining the home.

Fatigue is a common complaint that often goes beyond simple tiredness. It’s a profound exhaustion that doesn’t improve much with rest and can make even small activities feel overwhelming. Getting dressed, preparing meals, or walking to the mailbox may require significant effort. This type of fatigue can result from the cancer itself, from anemia due to bleeding, or later from treatments like chemotherapy.^[1]

Frequent urination or pain and burning during urination can disrupt sleep and make it difficult to attend social events, travel, or sit through meetings at work. The constant need to locate bathrooms and the discomfort associated with urinating can cause people to limit their activities and avoid situations where bathroom access might be uncertain.

Emotionally, receiving a cancer diagnosis often triggers a range of intense feelings. Fear and anxiety about the future are common, particularly regarding how the disease will progress and what treatments will involve. Many patients experience worry about their survival and what will happen to their loved ones. Sadness or depression may develop, especially if the cancer and its treatments limit previously enjoyed activities.

The uncertainty surrounding cancer can be particularly difficult to bear. Questions about whether treatment will work, whether the cancer will come back, or whether it has already spread can create constant worry. Some people find themselves thinking about their mortality in ways they never had before, which can be both frightening and emotionally draining.

Social relationships may be strained in unexpected ways. Some patients feel isolated because friends and family members don’t know what to say or how to help. Others may withdraw from social activities because they don’t feel well enough to participate or because they’re uncomfortable discussing their illness. Family dynamics can shift as loved ones take on caregiving roles, which can create both closeness and tension.

Work life often requires adjustment. Depending on the stage of cancer and the intensity of treatment, some patients can continue working with modifications, while others need to take medical leave. Fatigue, medical appointments, and side effects from treatment can make it challenging to maintain previous levels of productivity. Financial concerns may arise if work hours are reduced or employment is interrupted, adding stress to an already difficult situation.

For those who need surgery—often a nephroureterectomy, which involves removing the kidney, ureter, and a portion of the bladder—there is an adjustment period during recovery. Most people can live healthy lives with one kidney, but the initial recovery from surgery involves pain, limitation of physical activities, and time away from normal routines.

Despite these challenges, many patients develop coping strategies that help them maintain quality of life. Breaking large tasks into smaller, manageable pieces can help conserve energy. Prioritizing the most important activities and asking for help with others allows people to focus their limited energy where it matters most. Some find that gentle exercise, when approved by their doctor, actually helps reduce fatigue and improves mood.

Maintaining open communication with healthcare providers about symptoms and concerns ensures that problems are addressed promptly. Connecting with support groups, either in person or online, can provide emotional support and practical advice from others who understand what it’s like to live with this cancer. Professional counseling or therapy can also be valuable for processing the emotional impact of the diagnosis and developing healthy coping mechanisms.

Planning ahead for medical appointments, organizing medications, and keeping track of symptoms in a journal can help patients feel more in control of their situation. Having a trusted friend or family member accompany you to appointments can provide emotional support and help remember important information the doctor shares.

Support for Family: Helping Your Loved One Through Clinical Trials

Family members play a crucial role in supporting patients with transitional cell cancer of the renal pelvis and ureter, particularly when it comes to exploring all available treatment options, including clinical trials. Understanding what clinical trials are and how to help your loved one consider them is an important part of being a supportive family member.

Clinical trials are research studies that test new ways to prevent, detect, or treat cancer. They are designed to determine whether new treatments are safe and effective and whether they work better than existing treatments. For transitional cell cancer of the renal pelvis and ureter, clinical trials might test new chemotherapy drugs, new combinations of existing drugs, new immune therapies, or new surgical techniques.

Because this cancer is relatively rare compared to other types of cancer, participating in clinical trials can be especially important. It provides access to cutting-edge treatments that aren’t yet available to the general public and contributes to medical knowledge that will help future patients. As one oncologist noted, there are now “a large number of treatments, ranging from surgery to immune therapies to chemotherapies, including combinations” being studied for upper tract cancers.^[1]

As a family member, you can help your loved one understand and explore clinical trial options in several ways. Start by having an open conversation about clinical trials. Some patients may have misconceptions—such as believing that clinical trials mean receiving a placebo with no treatment, or that they are only for people who have exhausted all other options. In reality, many trials compare new treatments to the current standard of care, ensuring all participants receive active treatment. Trials are available for all stages of cancer, not just advanced disease.

Help research what clinical trials are available. You can search clinical trial databases online, with www.clinicaltrials.gov being a comprehensive resource maintained by the U.S. government. Look for trials that match your loved one’s specific type and stage of cancer, location, and other medical conditions. Make a list of trials that seem potentially suitable to discuss with their doctor.

Attend medical appointments with your loved one when possible. Having a second person present helps ensure that all information is heard and remembered. During these appointments, don’t hesitate to ask the doctor about clinical trial options. Questions you might ask include: “Are there any clinical trials that might be appropriate for this situation?” “What are the potential benefits and risks of participating in a trial compared to standard treatment?” “How would participating in a trial affect my loved one’s daily life and treatment schedule?”

If a clinical trial seems like a possibility, help your loved one gather and organize the necessary medical records and documentation. Trial enrollment often requires detailed information about previous treatments, test results, and overall health status. Having these materials organized and ready can speed up the enrollment process.

Understand that deciding whether to participate in a clinical trial is deeply personal. Your role is to support your loved one’s decision, whatever it may be, not to push them toward or away from participation. Some people feel empowered by contributing to cancer research; others prefer to stick with standard treatments they understand better. Both choices are valid.

If your loved one does enroll in a clinical trial, you can continue to help by assisting with transportation to appointments, which may be more frequent than with standard treatment. Help keep track of the study schedule, medication requirements, and any symptoms that need to be reported to the research team. Many trials require detailed symptom diaries—you can help with this documentation.

Be aware that participants in clinical trials can leave the study at any time if they choose. If the trial treatment is causing unacceptable side effects or if your loved one simply changes their mind, they have the right to discontinue participation and pursue other treatment options. This right is protected and should never be a source of guilt or pressure.

Finally, help maintain perspective throughout the treatment journey. Whether your loved one receives standard treatment or participates in a clinical trial, they will need emotional support, practical assistance, and someone to listen when they need to talk. Your presence and advocacy are valuable contributions to their care, regardless of which treatment path is chosen.